CrossrefInfokarte
OT01 | A PHASE 3 TRIAL OF OBINUTUZUMAB AND VENETOCLAX WITH OR WITHOUT ACALABRUTINIB IN PATIENTS WITH HIGH RISK CHRONIC LYMPHOCYTIC LEUKEMIA: CLL16 TRIAL OF THE GCLLSG
Hematological Oncology · 2025-06 · 43 (S3)
DOI: 10.1002/hon.70093_ot01 ↗Abstract
Kein Abstract verfügbar.
EUVIMED